An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

Clinical trial NCT07493044 · RECRUITING

Trial details

NCT number: NCT07493044
Sponsor: Guangzhou FineImmune Biotechnology Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma (HCC)GPC3 Positive Hepatocellular Carcinoma

Start date: 2026-03-27
Primary completion: 2028-04-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.